Commercial real estate time running out

A Time of Reckoning for Commercial Real Estate

After years of stretching loan terms and hoping the market would rebound on its own, banks across the country are finally calling in billions of dollars tied to troubled commercial real estate. The result? Default rates are breaking records and reigniting anxiety throughout the finance and property sectors.

According to the research firm Trepp, more than 12% of office loans were delinquent as of January—an all‑time high. With interest rates rising since 2022 and office revenues shrinking, banks have spent years modifying and reclassifying loans just to keep borrowers afloat. But now, the bill is coming due.

Assistant professor Maggie Hu from Baruch College’s Department of Real Estate told CFO Brew that many loans simply “don’t refinance cleanly” anymore. Weak cash flows, lower valuations, and shifting office demand have transformed what once was a stable sector into a puzzle of declining returns and hard decisions.

The End of “Extend and Pretend”

The pandemic left offices empty as remote work surged—yet lenders largely chose to extend maturing loans rather than confront the steep drop in value. That strategy temporarily kept the market afloat, but now banks face pressure from investors and regulators to clean up their balance sheets.

This urgency has created what Hu describes as a “bifurcated and uneven” industry. Older or less desirable buildings are suffering the most, while newer, flexible spaces continue attracting tenants.

Adding to the pressure, $875 billion in commercial and multifamily loans—about 17% of all outstanding debt—is set to mature in 2026, according to the Mortgage Bankers Association. Even though this is slightly lower than last year, it remains historically high and signals a difficult refinancing wave ahead.

Regional Banks in the Hot Seat

Smaller regional banks are feeling the strain. Because they typically hold more localized commercial portfolios, they are more exposed to office-sector declines. If losses rise beyond tolerable levels, lending standards across all industries—not just real estate—could tighten dramatically.

This means capital becomes harder to access, growth slows, and ripple effects could spread across the economy. For many real estate, finance, mortgage, and insurance professionals, this is a defining moment.

What CRE Companies Must Do Now

For commercial real estate owners facing upcoming loan maturities, preparation is everything. Hu advises companies to engage lenders early, present updated assessments, and offer realistic solutions rather than simply asking for more time.

“Communicating effectively with lenders is essential,” Hu emphasized, noting that renewals are no longer guaranteed in today’s environment.

Why This Matters for Today’s Professionals

Whether you’re in real estate, finance, lending, investment, or risk management, shifting commercial property dynamics are reshaping the professional landscape. Understanding data-driven management—vacancy trends, absorption rates, tenant strategy—is now essential.

For those looking to elevate their expertise, schools like Cameron Academy provide cutting-edge courses to keep professionals informed and competitive. From Florida real estate licensing to continuing education across multiple industries, staying ahead has never been more important.

Explore the original reporting and dive deeper into the data by visiting the full CFO Brew article: CFO Brew – A Time of Reckoning for Commercial Real Estate.

More Articles

Getting licensed or staying ahead in your career can be a journey—but it doesn’t have to be overwhelming. Grab your favorite coffee or tea, take a moment to relax, and browse through our articles. Whether you’re just starting out or renewing your expertise, we’ve got tips, insights, and advice to keep you moving forward. Here’s to your success—one sip and one step at a time!

The AI Boom in Cancer: Game-Changer or Just Hype?

The promise of artificial intelligence (AI) in the field of oncology is nothing short of revolutionary. As the world grapples with the complexities of cancer, AI is emerging as a potential game-changer in diagnostics, treatment personalization, and drug discovery.

By |January 15, 2025|Categories: Article, Healthcare, Technology|Tags: |0 Comments

HHS Unveils AI Strategic Plan to Revolutionize Healthcare

The U.S. Department of Health and Human Services (HHS) has unveiled its ambitious AI Strategic Plan, a comprehensive blueprint aimed at revolutionizing healthcare, human services, and public health through the transformative power of artificial intelligence.

By |January 15, 2025|Categories: Article, Artificial Intelligence, Healthcare|Tags: , |0 Comments

United States Naval Academy Class of 2024 Graduation

The ceremony was graced by the presence of three distinguished speakers, whose words of wisdom and encouragement left a lasting impression on the attendees.

By |January 14, 2025|Categories: Article, Education, Military|Tags: , |0 Comments

AI Certifications: The Key to Future-Proofing Your Career

In the fast-paced world of artificial intelligence (AI), staying current with the latest technological advancements is crucial for professionals aiming to excel in their careers. As businesses increasingly integrate AI into their operations, the demand for skilled AI experts is surging.

By |January 14, 2025|Categories: Article, Education, Technology|Tags: , |0 Comments

Telemedicine: A Digital Revolution in Healthcare Amid COVID-19

The year 2020 marked a significant turning point in the global healthcare landscape, as the COVID-19 pandemic accelerated the adoption of digital technologies such as telemedicine.

By |January 14, 2025|Categories: Article, Healthcare, Technology|Tags: , |0 Comments

Genomic Biomarkers Market Thrives with Personalized Medicine Boom

The genomic biomarkers market is witnessing a significant surge, driven by the burgeoning demand for personalized medicine. According to the latest report, the market is projected to grow to $14.09 billion by 2028, marking a compound annual growth rate (CAGR) of 17.4%. This approach not only optimizes treatment effectiveness but also minimizes side effects, making it a cornerstone of modern healthcare.